Use of Matched Unrelated Donors Compared with Matched Related Donors Is Associated with Lower Relapse and Superior Progression-Free Survival after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation
Open Access
- 29 December 2010
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 17 (8), 1196-1204
- https://doi.org/10.1016/j.bbmt.2010.12.702
Abstract
No abstract availableKeywords
Funding Information
- Ted and Eileen Pasquarello Research Fund, NIH Grants (CA142106, PO1HL070149-02)
- Jock and Bunny Adams Education and Research Fund
This publication has 36 references indexed in Scilit:
- Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid LeukemiaJournal of Clinical Oncology, 2010
- Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remissionLeukemia, 2010
- Sibling versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia: Refined HLA Matching Reveals More Graft-versus-Host Disease but not Less RelapseTransplantation and Cellular Therapy, 2009
- Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease Prophylaxis after Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell TransplantationTransplantation and Cellular Therapy, 2009
- The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantationBlood, 2009
- Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity ConditioningJournal of Clinical Oncology, 2008
- Comparable Outcomes after Nonmyeloablative Hematopoietic Cell Transplantation with Unrelated and Related DonorsTransplantation and Cellular Therapy, 2007
- Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantationBlood, 2006
- Unrelated Donor Status and High Donor Age Independently Affect Immunologic Recovery after Nonmyeloablative ConditioningTransplantation and Cellular Therapy, 2006
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999